Skip to main content

 11VL | pdb_000011vl

Effector BcTde1 in complex with BcTdi1 mutant G157R

  • Classification: TOXIN
  • Organism(s): Bacillus cereus
  • Expression System: Escherichia coli
  • Mutation(s): Yes 

  • Deposited: 2026-03-13 Released: 2026-09-30 
  • Deposition Author(s): Bosch, D.E.
  • Funding Organization(s): National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.221 (Depositor), 0.222 (DCC) 
  • R-Value Work: 
    0.168 (Depositor), 0.172 (DCC) 
  • R-Value Observed: 
    0.170 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 11VL

This is version 1.0 of the entry. See complete history. 

Literature

Secreted nuclease effector neutralization by active site mimicry in Bacillota.

Abbasian, R., Parajuli, B., Yu, L., Durocher, B., Gardner, E., Chodur, E., Dwelley, M.K., Ellermeier, C.D., Ho, T.D., Bosch, D.E.

(2026) mBio 17: e0151626-e0151626

  • DOI: https://doi.org/10.1128/mbio.01516-26
  • Primary Citation Related Structures: 
    11UX, 11UZ, 11VD, 11VF, 11VH, 11VK, 11VL, 11VM

  • PubMed Abstract: 

    Polymorphic toxins mediate interbacterial antagonism among competitors in the gut microbiome. Nuclease effectors, distantly related to the type VI-secreted Bacteroidales Tde, are enriched in human gut Bacillota. Tde mediates antagonism among Bacillota, and expression of the cognate immunity, Tdi, in recipients is protective. Crystal structures of Tde/Tdi complexes from two Bacillus spp. and Enterococcus quebecensis highlight a conserved mechanism of immunity. Tdi engages Tde with high-affinity, specific binding at an interface that features predominantly polar amino acids. A separate Tdi interface has a very highly conserved P(Φ) 4 GG motif that structurally mimics and displaces a short helix in Tde's active site, which contains the critical catalytic residues. An isolated P(Φ) 4 GG motif peptide is sufficient for Tde nuclease activity inhibition at high concentrations. However, key residues at both the polar interface and P(Φ) 4 GG are required for complete inhibition of nuclease activity and protection against toxicity. We propose a multivalent Tde/Tdi neutralization mechanism where an initial high-affinity interface increases the local concentration of Tdi's P(Φ) 4 GG motif, enabling it to displace the Tde active site through structural mimicry. The resulting conformational rearrangement of Tde increases its flexibility in solution and susceptibility to proteolysis, which may aid in eliminating the toxic effector.IMPORTANCEBacteria in the gut microbiome compete using toxin secretion systems. Prior research has emphasized the importance of secretion systems in gram-negative bacteria. We describe a class of secreted nuclease effectors (toxins) and protective immunity proteins that are enriched in gram-positive Bacillota in human gut microbiomes. These effector/immunity pairs mediate antagonism among Bacillus and Enterococcus spp. The immunity proteins neutralize the nuclease effector through a unique mechanism of enzymatic active site mimicry. The immunity proteins bind effectors with very high-affinity at an interface with polar residues. The effector undergoes a large conformational change. A very highly conserved motif on the immunity surface competitively displaces an active site short helix and loop that contains the key catalytic residues. This rearrangement of the effector renders it inactive and susceptible to elimination by proteolysis.


  • Organizational Affiliation: 
    • Pathology Department, University of Iowa, Iowa City, Iowa, USA.

Macromolecule Content 

  • Total Structure Weight: 83.28 kDa 
  • Atom Count: 5,740 
  • Modeled Residue Count: 621 
  • Deposited Residue Count: 710 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Tde1
A, C
170Bacillus cereusMutation(s): 0 
Gene Names: COK98_17145
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Tdi
B, D
185Bacillus cereusMutation(s): 1 
Gene Names: C1N66_23170, COK98_17150
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.221 (Depositor), 0.222 (DCC) 
  • R-Value Work:  0.168 (Depositor), 0.172 (DCC) 
  • R-Value Observed: 0.170 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.995α = 88.53
b = 53.132β = 69.8
c = 74.711γ = 83.8
Software Package:
Software NamePurpose
PHENIXrefinement
Aimlessdata scaling
DIALSdata reduction
PHENIXphasing
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data

  • Released Date: 2026-09-30 
  • Deposition Author(s): Bosch, D.E.

Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesK08AI159619

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-30
    Type: Initial release